AUPH β€” AURINIA PHARMACEUTICALS INC

Ownership history in BAILARD, INC.  Β·  12 quarters on record

This page tracks every 13F SEC filing in which BAILARD, INC. reported a position in AURINIA PHARMACEUTICALS INC (AUPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.23% (2021 Q3)
πŸ“Š Avg. % of fund
0.09%
πŸ“… First filed
2020 Q2
πŸ“… Last filed
2025 Q3
⏱ Quarters held
12

Position Intelligence

BAILARD, INC. Γ— AUPH AI Analytics

πŸ“‰ BAILARD, INC. underperformed the S&P 500 by –36.5% annually on this AUPH position. Timing score: 44% (4/9 decisions correct). Average cost basis: $14.18. Maximum drawdown during holding period: –63.0%.

πŸ“ˆ Position Alpha vs SPY
-36.5%
annualised excess return

❌ Significantly underperformed the S&P 500 by 36.5% ann.
11 quarters analyzed

⏱️ Timing Score
44%

⚠️ Poor timing β€” buys often preceded drops, trims preceded rallies.
4 of 9 add/trim decisions correct

πŸ’° Entry Quality
$14.18
-22.1% vs current ($11.05)

Best entry: $12.96 (2021 Q2)  Β·  Worst: $16.25 (2020 Q2)

πŸ›‘οΈ Drawdown Resilience
–63.0%
max drawdown while held

πŸ’ͺ Held through 2 major drawdowns (>20%).

πŸ’ͺ Fund Conviction
44%
buy-side decisions

4 adds Β· 5 trims. Bought during 3 of 8 down-price quarters. πŸ“‰ Predominantly trimming β€” distribution phase.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    AUPH price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 11,700 β€” 0% 0.00% $129K $11.05
2025 Q2 REDUCED 11,700 -2,600 -18.2% 0.00% $99K $8.47
2024 Q4 REDUCED 14,300 -49,500 -77.6% 0.00% $128K $8.98
2022 Q2 REDUCED 63,800 -26,200 -29.1% 0.03% $641K $10.05
2022 Q1 UNCHANGED 90,000 β€” 0% 0.04% $1.1M $12.38
2021 Q4 REDUCED 90,000 -219,000 -70.9% 0.07% $2.1M $22.87
2021 Q3 REDUCED 309,000 -61,000 -16.5% 0.23% $6.8M $22.13
2021 Q2 ADDED 370,000 +56,000 +17.8% 0.17% $4.8M $12.96
2021 Q1 ADDED 314,000 +103,000 +48.8% 0.15% $4.1M $12.98
2020 Q4 UNCHANGED 211,000 β€” 0% 0.13% $2.9M $13.83
2 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding AUPH

As of 2025 Q4 β€” sorted by position size

TANG CAPITAL MANAGEMENT LLC 3Y 7Y 8.93% KOTLER KEVIN 4.57% NEA Management Company, LLC 3Y 7Y 3.23% nVerses Capital, LLC 0.91% IRONWOOD INVESTMENT MANAGEMENT LLC 3Y 7Y 0.77% Neo Ivy Capital Management 3Y 7Y 0.58% Uniplan Investment Counsel, Inc. 3Y 7Y 0.54% PSP Research LLC 0.47% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 0.44% HUSSMAN STRATEGIC ADVISORS, INC. 3Y 7Y 0.4%
← Back to BAILARD, INC. Holdings